Chile
Diabetes country report 2000 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Chile (CL)
| 2000 | 131.1 thousand |
| 2011 | 1.2 million |
| 2024 | 1.9 million |
| 2050 | 2.4 million |
Chile is one of the 21 countries and territories in the IDF South and Central America Region. Chile has the fifth highest diabetes prevalence (20-79 years) in the Region.
Data source(s) used for the diabetes estimates in adults:
- Petermann-Rocha F., Ulloa N., Adela M., et al. Nutrition . Nov-Dec 2020;79-80:110932. doi: 10.1016/j.nut.2020.110932. Epub 2020 Jul 3. PMID:32847773
- Departamento de EpidemiologÃa División de Planificación Sanitaria SubsecretarÃa de Salud Pública Santiago, Noviembre 2017
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | 131.1 | 1,190.1 | 1,863.7 | 2,381.2 |
| Age-standardised prevalence of diabetes, % | - | 9.5 | 12.2 | 13.7 |
| Proportion of people with undiagnosed diabetes, % | - | - | 17.1 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 318.7 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 716.9 | 823.3 |
| Age-standardised prevalence of IFG, % | - | - | 4.8 | 5.1 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 761.5 | 1,773.7 | 2,056.6 |
| Age-standardised prevalence of IGT, % | - | 6.2 | 11.9 | 12.7 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 7,927.0 | 9,444.9 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 13.4 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | 25,748.8 | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 10.7 | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 1,373.2 | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 6,657.3 | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 2,982.0 | 3,136.6 |
| Total diabetes-related health expenditure, ID million | - | - | 4,723.5 | 4,968.3 |
| Diabetes-related health expenditure per person, USD | - | 1,042.0 | 1,600.0 | 1,317.2 |
| Diabetes-related health expenditure per person, ID | - | - | 2,534.4 | 2,086.5 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 40,712.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 7,090.1 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | 9,405.0 | 11,680.5 | 14,309.9 | 15,036.4 |
| Population of children and adolescents (0-19 y) | - | - | 4,567,439.0 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | 131.1 |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | 9,405.0 |
| Population of children and adolescents (0-19 y) | - |
